News Overview

According to its Monday exchange statement, the brokerage's net profit increased 41.53% to Rs 423.83 crore for the September quarter.

Recommendation: Buy; Target Price: Rs 2,450

Glenmark Pharmaceuticals holds a portfolio of 188 products authorized for distribution in the U.S. market, along with 50 ANDA applications awaiting approval from the U.S. FDA.

The company has an office at Udyog Vihar in Gurgaon and its corporate headquarters are currently located at Nelson Mandela Marg in New Delhi.

Analysts of IIFL Capital Services raise revenue forecasts for FY24/25/26 by 22/59/57% to Rs99/189/220bn, respectively; contributing 55-60% of its revenues and 45-50% of Ebitda over FY25-26.

Healthy growth in volumes, EBITDA per ton to drive performance.

Analysts of IIFL Capital Services see OMCs plays on POL fuel retailing as valuations remain compelling; volatility in oil price is an intermediate headwind.

Strong, all-round performance expected during the quarter.

KEC International's Transmission & Distribution (T&D) unit claimed in a regulatory filing that the projects were located in the Middle East, Australia, India, and the Americas.

The Rupee started the day at 83.22 rupees per dollar, indicating a 0.05 % gain from the previous day's closing rate of 83.28 rupees per dollar.